Article

ForbesForbes on 2017-11-06 19:15

Abbott's Generic Pharmaceutical Business To Continue Growth Led By Emerging Markets

The generic pharmaceuticals business has been trending well for Abbott Labs for some time now. It accounts for around 15% of the company’s value, ...

Related news